Scheduled Press Conferences for 2018 SABCS:

• Wednesday, December 5, 2018, Press Conference 1
  7:15-7:45 a.m. CT
• Wednesday, December 5, 2018, Press Conference 2
  12:15-12:45 p.m. CT
• Thursday, December 6, 2018
  7:30-8:30 a.m. CT
• Friday, December 7, 2018
  7:30-8:30 a.m. CT

Wednesday, December 5, 2018, Press Conference 1
7:15-7:45 a.m. CT

SABCS Co-director Carlos Arteaga, MD, director of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, will moderate a press conference featuring the following research:

• Phase III KATHERINE Clinical Trial Crossed Early Reporting Boundary and Met its Primary Endpoint
• Adjuvant Capecitabine Did Not Significantly Improve Outcomes for Patients With Early-stage Triple-negative Breast Cancer